Daniela Sartori

IRCCS Ospedale San Raffaele

Emailsartori.daniela@hsr.it

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Daniela Sartori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

4 Article

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies
Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., 2020, In: Breast Care. 15, 1, p. 30-37 8 p.
Research output: Contribution to journal › Article › peer-review
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Bersanelli, M., Giannarelli, D., De Giorgi, U., Pignata, S., Di Maio, M., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., Giusti, R., Filetti, M., Di Napoli, M., Calvetti, L., Cappetta, A., Ermacora, P., Zara, D., Barbieri, F., Baldessari, C., Scotti, V. & 53 others, Mazzoni, F., Veccia, A., Guglielmini, P. F., Maruzzo, M., Rossi, E., Grossi, F., Casadei, C., Cortellini, A., Verderame, F., Montesarchio, V., Rizzo, M., Mencoboni, M., Zustovich, F., Fratino, L., Cinieri, S., Negrini, G., Banzi, M., Sorarù, M., Zucali, P. A., Lacidogna, G., Russo, A., Battelli, N., Fornarini, G., Mucciarini, C., Bracarda, S., Bonetti, A., Pezzuolo, D., Longo, L., Sartori, D., Iannopollo, M., Cavanna, L., Meriggi, F., Tassinari, D., Corbo, C., Gernone, A., Prati, V., Carnio, S., Giordano, P., Dicorato, A. M., Verusio, C., Atzori, F., Carrozza, F., Gori, S., Castro, A., Pilotto, S., Vaccaro, V., Garzoli, E., Di Costanzo, F., Maiello, E., Labianca, R., Pinto, C., Tognetto, M. & Buti, S., 2020, In: Therapeutic Advances in Medical Oncology. 12, 1758835920968463.
Research output: Contribution to journal › Article › peer-review
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG: Therapeutic Advances in Medical Oncology
Federation of Italian Cooperative Oncology Groups (FICOG), 2020, In: Ther. Adv. Med. Oncol.. 12, 12 p.
Research output: Contribution to journal › Article › peer-review
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Bersanelli, M., Giannarelli, D., De Giorgi, U., Pignata, S., Di Maio, M., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., Giusti, R., Filetti, M., Di Napoli, M., Calvetti, L., Cappetta, A., Ermacora, P., Zara, D., Barbieri, F., Baldessari, C., Scotti, V. & 53 others, Mazzoni, F., Veccia, A., Guglielmini, P. F., Maruzzo, M., Rossi, E., Grossi, F., Casadei, C., Cortellini, A., Verderame, F., Montesarchio, V., Rizzo, M., Mencoboni, M., Zustovich, F., Fratino, L., Cinieri, S., Negrini, G., Banzi, M., Sorarù, M., Zucali, P. A., Lacidogna, G., Russo, A., Battelli, N., Fornarini, G., Mucciarini, C., Bracarda, S., Bonetti, A., Pezzuolo, D., Longo, L., Sartori, D., Iannopollo, M., Cavanna, L., Meriggi, F., Tassinari, D., Corbo, C., Gernone, A., Prati, V., Carnio, S., Giordano, P., Dicorato, A. M., Verusio, C., Atzori, F., Carrozza, F., Gori, S., Castro, A., Pilotto, S., Vaccaro, V., Garzoli, E., Di Costanzo, F., Maiello, E., Labianca, R., Pinto, C., Tognetto, M. & Buti, S., 2020, In: Therapeutic Advances in Medical Oncology. 12
Research output: Contribution to journal › Article › peer-review

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG: Therapeutic Advances in Medical Oncology

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG